Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Carlos Castañeda-Altamirano"'
Autor:
Javier Enciso-Benavides, Luis Alfaro, Carlos Castañeda-Altamirano, Nancy Rojas, José González-Cabeza, Nathaly Enciso, Fernando Riesco, Miluska Castillo, Javier Enciso
Publikováno v:
Heliyon, Vol 7, Iss 6, Pp e07273- (2021)
Triple-negative breast tumours (TNBTs) make up 15–20% of all breast tumours. There is no treatment for them, and the role that cancer stem cells (CSCs) have in carcinogenesis is still unclear, so finding markers and therapeutic targets in CSC exoso
Externí odkaz:
https://doaj.org/article/467dd4ccc65a41f5814d5cd04c288670
Autor:
Luis J. Alfaro, Nancy Rojas, Javier Enciso, Javier Enciso-Benavides, Nathaly Enciso, José González-Cabeza, Carlos Castañeda-Altamirano, Miluska Castillo, Fernando Riesco
Publikováno v:
CONCYTEC-Institucional
Consejo Nacional de Ciencia Tecnología e Innovación Tecnológica
instacron:CONCYTEC
Heliyon, Vol 7, Iss 6, Pp e07273-(2021)
Heliyon
Consejo Nacional de Ciencia Tecnología e Innovación Tecnológica
instacron:CONCYTEC
Heliyon, Vol 7, Iss 6, Pp e07273-(2021)
Heliyon
Triple-negative breast tumours (TNBTs) make up 15–20% of all breast tumours. There is no treatment for them, and the role that cancer stem cells (CSCs) have in carcinogenesis is still unclear, so finding markers and therapeutic targets in CSC exoso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c19803344f1fa775a60431fc9c90d289
Autor:
Felipe Vaca-Paniagua, Rosalia Quezada-Urban, Clara Estela Díaz Velásquez, Eva María Gómez García, Claudia Fabiola Méndez Catalá, Javier Oliver, Alejandra Franco, Cecilia Frecha, Cecilia Riggi, Claudia Carranza, Carlos Castañeda Altamirano, Ana Milena Gómez, Ana Lorena Montealegre, Sandra Gaitán Chaparro, Juan Javier López, Sandra Perdomo
Publikováno v:
Cancer Research. 79:4164-4164
Hereditary breast and ovarian cancer syndrome (HBOC) is an autosomal dominant disease mainly associated to high-risk pathogenic alleles in the BRCA1 and BRCA2 genes, but only in ~25% of HBOC cases. With the emergence of broader multi-gene panels, pop